These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 216823)

  • 1. Large cell bronchogenic carcinoma. Prolonged disease-free survival following chemotherapy.
    Vosika GJ
    JAMA; 1979 Feb; 241(6):594-5. PubMed ID: 216823
    [No Abstract]   [Full Text] [Related]  

  • 2. CCNU-adriamycin therapy in bronchogenic carcinoma.
    Trowbridge RC; Kennedy BJ; Vosika GJ
    Cancer; 1978 May; 41(5):1704-9. PubMed ID: 206337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
    Stolinsky DC; Bull FE; Pajak TF; Bateman JR
    Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior vena caval obstruction due to small-cell anaplastic lung carcinoma. Response to chemotherapy.
    Kane RC; Cohen MH
    JAMA; 1976 Apr; 235(16):1717-8. PubMed ID: 176480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive chemotherapy of small cell bronchogenic carcinoma.
    Cohen MH; Creaven PJ; Fossieck BE; Broder LE; Selawry OS; Johnston AV; Williams CL; Minna JD
    Cancer Treat Rep; 1977; 61(3):349-54. PubMed ID: 194691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small cell bronchogenic carcinoma. A prolonged remission following chemotherapy.
    Cohen MH
    JAMA; 1977 Jun; 237(23):2528. PubMed ID: 576972
    [No Abstract]   [Full Text] [Related]  

  • 7. A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma.
    Alberto P; Barrelet L; Chapuis B; Garcia B
    Eur J Cancer (1965); 1975 Nov; 11(11):795-9. PubMed ID: 767111
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination chemotherapy with methyl-CCNU, 5-fluorouracil, and vincristine in adenocarcinoma and large cell carcinoma of the lung.
    Bernath AM; Cohen MH; Ihde DC; Fossieck BE; Matthews MJ; Minna JD
    Cancer Treat Rep; 1976 Sep; 60(9):1393-4. PubMed ID: 189924
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
    Chahinian PA; Arnold DJ; Cohen JM; Purpora DP; Jaffrey IS; Teirstein AS; Kirschner PA; Holland JF
    JAMA; 1977 May; 237(22):2392-6. PubMed ID: 576939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechlorethamine (NSC-762) plus CCNU (NSC-79037) in the treatment of inoperable squamous and large cell carcinoma of the lung.
    Edmonson JH; Lagakos S; Stolbach L; Perlia CP; Bennett JM; Mansour EG; Horton J; Regelson W; Cummings FJ; Israel L; Brodsky I; Shnider BI; Creech R; Carbone PP
    Cancer Treat Rep; 1976 May; 60(5):625-7. PubMed ID: 186183
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of CCNU (NSC-79037) on bronchogenic carcinoma.
    Takita H; Brugarolas A
    J Natl Cancer Inst; 1973 Jan; 50(1):49-53. PubMed ID: 4348225
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination chemotherapy with CCNU (NSC-79037),hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in advanced bronchogenic carcinoma.
    DiBella NJ; Nelson RA; Norgard MJ
    Oncology; 1975; 32(2):82-5. PubMed ID: 815858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
    Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
    Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
    [No Abstract]   [Full Text] [Related]  

  • 14. [MACC plus thymostimulin (TP-1 Serono) therapy of small cell bronchogenic carcinoma. Clinico-immunologic evaluation of the results of a randomized trial].
    Salvati F; Pallotta G; Antilli A; Nunziati F; De Marinis F; Lucchesi M
    G Ital Chemioter; 1984; 31(1-2):185-9. PubMed ID: 6088341
    [No Abstract]   [Full Text] [Related]  

  • 15. Small-cell bronchogenic carcinoma--primary and relapse therapy with etoposide (VP-16), methotrexate and CCNU.
    Niederle N; Krischke W; Bremer K; Schmidt CG; Seeber S
    Cancer Treat Rev; 1982 Jun; 9 Suppl():101-5. PubMed ID: 6290053
    [No Abstract]   [Full Text] [Related]  

  • 16. Nitrosourea combinations in lung cancer.
    Livingston RB
    Cancer Treat Rep; 1976 Jun; 60(6):757-760. PubMed ID: 182365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.
    Vogelzang NJ; Trowbridge RC; Frenning DH; Theologides A; Kennedy BJ; Kelly DR; Ewing SL; Vosika GJ
    Cancer Treat Rep; 1980; 64(8-9):997-1000. PubMed ID: 6256076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCNU (NSC-409962) in the treatment of bronchogenic carcinoma.
    Whittington RM; Fairly JL; Majima H; Patno ME; Prentice R
    Cancer Chemother Rep; 1972 Dec; 56(6):739-43. PubMed ID: 4574055
    [No Abstract]   [Full Text] [Related]  

  • 19. CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma.
    Poplin EA; Aisner J; Van Echo DA; Whitacre M; Wiernik PH
    Cancer Treat Rep; 1982 Jul; 66(7):1557-9. PubMed ID: 6284360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate in the chemotherapy of lung cancer.
    Smyth JF; Ford HT
    Cancer Treat Rep; 1981; 65 Suppl 1():161-3. PubMed ID: 6275986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.